![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, October 20, 2017 4:56:39 AM
Recent QURE News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 11:48:04 AM
- uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease • GlobeNewswire Inc. • 08/15/2024 11:05:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/01/2024 12:54:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:51:41 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 11:43:22 AM
- uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update • GlobeNewswire Inc. • 08/01/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 11:10:32 AM
- uniQure Announces Closing of Sale of Manufacturing Facility to Genezen • GlobeNewswire Inc. • 07/23/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 11:13:10 AM
- uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease • GlobeNewswire Inc. • 07/09/2024 11:05:00 AM
- uniQure Announces Sale of Commercial Manufacturing Facility to Genezen • GlobeNewswire Inc. • 07/01/2024 11:05:00 AM
- Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA • PR Newswire (US) • 07/01/2024 11:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 12:53:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 12:49:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 10:00:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:46:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:40:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:24:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:19:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 10:42:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 11:18:51 AM
- uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease • GlobeNewswire Inc. • 06/03/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 12:03:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 11:57:14 AM
- uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress • GlobeNewswire Inc. • 05/07/2024 11:05:00 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM